US 12,246,051 B2
Aspergillus oryzae strain and use thereof
Hyeong Min Han, Seoul (KR); Sunghwan Hwang, Seoul (KR); Sung Hun Youn, Seoul (KR); Seunggon Na, Seoul (KR); and Sado Lee, Seoul (KR)
Assigned to LG HOUSEHOLD & HEALTH CARE LTD., Seoul (KR)
Filed by LG HOUSEHOLD & HEALTH CARE LTD., Seoul (KR)
Filed on May 30, 2023, as Appl. No. 18/325,252.
Claims priority of application No. 10-2022-0066545 (KR), filed on May 31, 2022.
Prior Publication US 2023/0381258 A1, Nov. 30, 2023
Int. Cl. A61K 36/258 (2006.01); A23L 31/00 (2016.01); A23L 33/105 (2016.01); A61K 36/062 (2006.01); C12N 1/14 (2006.01); C12R 1/69 (2006.01)
CPC A61K 36/258 (2013.01) [A23L 31/00 (2016.08); A23L 33/105 (2016.08); A61K 36/062 (2013.01); C12N 1/145 (2021.05); C12R 2001/69 (2021.05)] 9 Claims
 
1. A composition comprising a red ginseng fermentation product comprising an Aspergillus oryzae LGYM4 strain deposited with Accession No. KCTC 1453 3BP or a red ginseng fermentation product generated from an Aspergillus oryzae LGYM4 strain deposited with Accession No. KCTC 14533BP, wherein the composition is a food composition, a cosmetic composition, a quasi-drug composition, or a pharmaceutical composition, wherein the red ginseng fermentation product is in the form of a concentrate, wherein the red ginseng fermentation product has an increased content of the (R) type ginsenoside Rg3 as compared to a composition including red ginseng before fermentation, and wherein the red ginseng fermentation product has a decreased content of the Rg1 and Rd ginsenosides as compared to a composition including red ginseng before fermentation.